Summary: Now approved for use in the United States, the Tecnis Symfony IOL (Abbott) offers a long-awaited treatment option for patients looking to achieve spectacle independence without compromising near vision. In this episode, Kevin Waltz, MD, shares his experience with this lens, from the first clinical trial in Honduras to today. Jason Jones, MD, also provides pearls for using the Symfony IOL and discusses the future applications of this technology.
